Arsenite, arsenate and vanadate affect human erythrocyte membrane

Journal of Inorganic Biochemistry

Volumn 79, Issue 1-4, 2000, Pages 195-203

  Zhang, Tian Lan ^a   Gao, Yu Xi ^b   Lu, Jing Fen ^a   Wang, Kui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

Author keywords

Arsenate; Arsenite; Human erythrocyte; Membrane proteins; Vanadate

Indexed keywords

ARSENIC ACID; ARSENIC TRIOXIDE; MEMBRANE PROTEIN; VANADIC ACID;

ARTICLE; BINDING KINETICS; ERYTHROCYTE GHOST; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE BINDING; POLYACRYLAMIDE GEL ELECTROPHORESIS;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ARSENATES; ARSENIC; ARSENITES; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HUMANS; KINETICS; MEMBRANE LIPIDS; MEMBRANE PROTEINS; SODIUM COMPOUNDS; VANADATES;

EID: 0034732637     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00155-5     Document Type: Article

References (37)

1. Dhubhghaill O.M.N., Sadler P.J. Struct. Bonding. 78:1991;130-190.
2. IARC, Arsenic and Arsenic Compounds. Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. vol. 23, WHO, Lyon, 1980, pp. 37-141.
3. Lu D.P., Qui J.Y., Chen S.S. et al. Blood. 90:1997;416a.
4. Dai J., Weinberg R.S., Waxman S. et al. Blood. 93:1999;268-277.
5. Li Y.M., Broome J.D. Cancer Res. 59:1999;776-780.
6. Rousselot P., Labaume S., Marolleau J.P. et al. Cancer Res. 59:1999;1041-1048.
7. Chen G.Q., Zhu J., Chen Z. et al. Blood. 88:1996;1052-1061.
8. Xu C., Zhou T., Kuroda M. et al. J. Biochem. (Tokyo). 123:1998;16-23.
9. Silver S. J. Ind. Microbiol. Biotechnol. 20:1998;1-12.
10. Healy S.M., Casarez E.A., Aposhian H.V. et al. Toxicol. Appl. Pharmacol. 148:1998;65-70.
11. Vahter M., Norin H Environ. Res. 21:1980;446-457.
12. Thompson D.J. Chem.-Biol. Interact. 88:1993;89-114.
13. Winski S.L., Carter D.E. J. Toxicol. Environ. Health. 46:1995;379-397.
14. Wang Z., Dey S., Rossman T.G. Toxicol. Appl. Pharmacol. 137:1996;112-119.
15. Winski S.L., Carter D.E. J. Toxicol. Environ. Health, Part A. 53:1998;345-355.
16. H. Schenkel-Brunner, Human Blood Groups: Chemical and Biochemical Basis of Antigen Specificity, Springer, Berlin, 1995, Ch. 4.
17. Cantley Jr L.C., Resh M.D., Guidotti G. Nature. 272:1978;552-554.
18. Mosior M., Krawczak-Sadowska T., Gomulkiewicz H.J. Gen. Physiol. Biophys. 11:1992;337-343.
19. Repetto G., Sanz P., Repetto M. Toxicology. 92:1994;143-153.
20. Vahter M., Marafante E. Chem.-Biol. Interact. 47:1983;29-44.
21. H. Sigel, A. Sigel, Metal Ions in Biological Systems, vol. 31, Marcel Dekker, New York, 1995.
22. D.M. Shotton, in: J.E. Celis (Ed.), Cell Biology. A Laboratory Handbook, 2nd ed., Academic Press, San Diego, 1998, pp. 26-33.
23. Lowry O.H., Rosebrough N.J., Farr A.L. et al. J. Biol. Chem. 193:1951;256-275.
24. Ellman G.L. Arch. Biochem. Biophys. 82:1959;70-77.
25. Laemmli U.K. Nature. 227:1970;580-685.
26. J.F. Robyt, B.J. White, Biochemical Techniques: Theory and Practice, Brooks/Cole, Monterey, CA, 1987, pp. 143-145.
27. G. Lenay, in: R.A. Capald (Ed.), Membrane Proteins and Their Interaction with Lipid, Academic Press, New York, 1977, p. 47.
28. Ship S., Shami Y., Breuer W. J. Membrane Biol. 33:1977;311-323.
29. Tanner M.J.A. J. Membrane Biol. 14:1997;155-165.
30. H.M. McConnell, in: L.J. Berliner (Ed.), Spin Labeling: Theory and Applications, Academic Press, New York, pp. 542-543.
31. I.C.P. Smith, in: H.M. Swartz, J.R. Bolton, D.C. Borg (Eds.), Biological Applications of Electron Spin Resonance, Wiley, New York, p. 491.
32. Delnomdedieu M., Styblo M., Thomas D.J. Chem.-Biol. Interact. 98:1995;69-83.
33. Kenney L.J., Kaplan J.H. J. Biol. Chem. 263:1988;7954-7960.
34. Huang R.-N., Lee T.-C. Toxicol. Appl. Pharmacol. 136:1996;243-249.
35. Wang K. S. Afr. Tydskr. Chem. 50:1997;232-239.
36. Delnomdedieu M., Basti M.M., Styblo M. et al. Chem. Res. Toxicol. 7:1994;621-627.
37. Jacob H.S., Jandl J.H. J. Clin. Invest. 41:1962;779-792.